Zhejiang, China

Yongqiang Shi

This inventor holds 1 USPTO granted patent. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongqiang Shi. Retrieved from https://idiyas.com/inventor/yongqiang-shi-ferqqf3x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yongqiang Shi: Innovator in Immune-Related Disorders

Introduction

Yongqiang Shi is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target immune-related disorders. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Yongqiang Shi holds a patent for a PD-L1 antagonist compound. This patent includes a compound of Formula (I) and a pharmaceutical composition thereof. The method described in the patent is aimed at preventing and/or treating immune-related disorders, showcasing his innovative approach to addressing complex health issues.

Career Highlights

Yongqiang Shi is currently employed at Adlai Nortye Biopharma Co., Ltd. His role at the company allows him to leverage his expertise in drug development and contribute to groundbreaking research in the pharmaceutical industry. His dedication to innovation is evident in his work and the impact it has on healthcare.

Collaborations

Yongqiang has collaborated with esteemed colleagues such as Zhiyong Yu and Pan Li. These partnerships highlight the importance of teamwork in the pursuit of scientific advancements and the development of effective treatments.

Conclusion

Yongqiang Shi is a prominent figure in the field of pharmaceutical innovation, with a focus on immune-related disorders. His patent for a PD-L1 antagonist compound exemplifies his commitment to improving healthcare through scientific research. His contributions are paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…